Dataset Information


Genome-wide map of PAX3-FKHR binding sites in rhabdomyosarcoma

ABSTRACT: We report the genome-wide maps of PAX3-FKHR binding sites. Chromatin immunoprecipitation was performed against PAX3-FKHR positive (Rh4) and PAX3-FKHR negative (RD) rhabdomyosarcoma cells with a monoclonal antibody (pFM2) specific for the fusion region of PAX3-FKHR. We obtained 4 million sequence tags for both input and ChIP DNA that aligned to the human genome. We identified 1,463 binding sites from ChIP-seq of Rh4 cells, none of which appeared from ChIP-seq of fusion negative RD cells. The PAX3-FKHR binding sites were found to associate with 1,072 genes in RMS cells. The data shows that PAX3-FKHR binds to the same sites as PAX3, at the enhancers for MYF5, FGFR4, and the MYOD core enhancer previously shown to be regulated by PAX3. Moreover, our dataset has the precision for rapid identification and validation of novel and specific sequences required for the enhancer activity of MYOD and FGFR4. The genome wide analysis reveals that the PAX3-FKHR sites are: 1) mostly distal to transcription start sites; 2) conserved; 3) enriched for PAX3 motifs; and 4) strongly associated with genes over-expressed in PAX3-FKHR positive RMS cells and tumors. There is little evidence in our dataset for PAX3-FKHR binding at the promoters. In one instance, we show two intronic enhancer elements for MET, rather than at the previously described promoter. The genome-wide analysis further illustrates a strong association between PAX3 and E-box motifs in these binding sites, suggestive of a common co-regulation for many target genes. The map of PAX3-FKHR binding sites provides new links for PAX3 and PAX3-FKHR functions and new targets for RMS therapy. Examination of PAX3-FKHR binding sites in translocation-positive rhabdomyosarcoma cells via ChIP-seq with an antibody specific for the fusion protein.

ORGANISM(S): Homo sapiens  

SUBMITTER: Sean Davis   Sven Bilke  Liang Cao  Paul S Meltzer 

PROVIDER: E-GEOD-19063 | ArrayExpress | 2010-08-17



altmetric image


Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer.

Cao Liang L   Yu Yunkai Y   Bilke Sven S   Walker Robert L RL   Mayeenuddin Linnia H LH   Azorsa David O DO   Yang Fan F   Pineda Marbin M   Helman Lee J LJ   Meltzer Paul S PS  

Cancer research 20100727 16

The PAX3-FKHR fusion protein is present in a majority of alveolar rhabdomyosarcomas associated with increased aggressiveness and poor prognosis. To better understand the molecular pathogenesis of PAX3-FKHR, we carried out the first, unbiased genome-wide identification of PAX3-FKHR binding sites and associated target genes in alveolar rhabdomyosarcoma. The data shows that PAX3-FKHR binds to the same sites as PAX3 at both MYF5 and MYOD enhancers. The genome-wide analysis reveals that the PAX3-FKHR  ...[more]

Similar Datasets

2010-08-17 | GSE19063 | GEO
2012-05-15 | E-GEOD-35862 | ArrayExpress
| GSE69439 | GEO
| GSE52677 | GEO
| GSE15489 | GEO
| GSE92689 | GEO
| PRJNA120571 | ENA
| GSE15103 | GEO
2009-08-27 | E-GEOD-15489 | ArrayExpress
| GSE84629 | GEO